Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.
Looking for a particular Gamida Cell Ltd. employee's phone or email?
Gamida Cell Ltd. Questions
The Gamida Cell Ltd. annual revenue was $35.1 million in 2026.
Ronit Simantov is the Chief Medical Officer of Gamida Cell Ltd..
83 people are employed at Gamida Cell Ltd..
Gamida Cell Ltd. is based in Boston, Massachusetts.
The NAICS codes for Gamida Cell Ltd. are [325, 3254, 54, 32541, 541, 32].
The SIC codes for Gamida Cell Ltd. are [283, 87, 28, 873].
Top Gamida Cell Ltd. Employees
-
Ronit Simantov
Chief Medical Officer at Gamida Cell Ltd.
New York, NY, US23 -
Rocio Manghani
Senior Vice President, Market Access at Gamida Cell Ltd.
San Diego, CA, US45+ -
25+
-
22
-
13
-
2
-
Tami Greenberg
VP of Quality at Gamida Cell Ltd.
Be'er Sheva, IL1
Related Companies
